Processa Pharmaceuticals, Inc. PCSA
Set alert
1.89 USD 0.00 0.00%
At close · Oct 30
1.86 -0.03 -1.59%
After hours · Oct 30, 4:00 PM ET
1.81 Day range 1.94
1.04 52-week range 10.25
- YTD
- -34.38%
- 1 year
- -78.72%
- Open
- 1.81
- Prev close
- 1.89
- Mkt cap
- 5.29M
- Vol
- 25.32K
- Avg vol
- 88.98K
- EPS
- -4.33
- P/E
- 0.00
- Div yield
- 0.00%
More statistics
- Low
- 1.81
- High
- 1.94
- Forward P/E
- -0.39
- Beta
- 0.60
- Short ratio
- 2.45
- Inst. own
- 1.49%
- Dividend
- 0.00
- Ex-div date
- 50-d avg
- 1.13
- 200-d avg
- 1.62
- 1y target
- 6.00
Financial health
Altman Z-Score
-92.95 Distress zone
Bankruptcy-risk model: below 1.81 distress, above 2.99 safe.
Piotroski F-Score
1 / 9 Weak
Nine pass/fail tests of profitability, leverage and efficiency.
FMP rating
B-2 / 5 overall
- DCF 5
- Return on Equity 5
- Return on Assets 1
- Debt / Equity 1
- P/E 1
- P/B 1
Valuation
P/E -0.3×
FY 2016 5y median -0.6× FY 2025
P/S 0.0×
FY 2016 5y median 0.0× FY 2025
P/B 0.7×
FY 2016 5y median 1.8× FY 2025
P/FCF -0.3×
FY 2016 5y median -1.1× FY 2025
EV/EBITDA 0.1×
FY 2016 5y median -0.4× FY 2025
EV/Sales 0.0×
FY 2016 5y median 0.0× FY 2025
FCF Yield -301.9%
FY 2016 5y median -91.9% FY 2025
Profitability
Gross Margin 0.0%
FY 2016 5y median 0.0% FY 2025
Operating Margin 0.0%
FY 2016 5y median 0.0% FY 2025
Net Margin 0.0%
FY 2016 5y median 0.0% FY 2025
ROE -243.2%
FY 2016 5y median -243.2% FY 2025
ROIC -250.8%
FY 2016 5y median -250.8% FY 2025
ROA -173.6%
FY 2016 5y median -192.2% FY 2025
Growth (YoY)
Revenue 0.0%
FY 2016 FY 2025
Operating Income -16.1%
FY 2016 FY 2025
EPS (diluted) 89.3%
FY 2016 FY 2025
Free Cash Flow -1.2%
FY 2016 FY 2025
Financial Health
Current Ratio 2.5×
FY 2016 5y median 7.7× FY 2025
Quick Ratio 2.5×
FY 2016 5y median 7.7× FY 2025
Debt / Equity 0.0×
FY 2016 5y median 0.0× FY 2025
Net Debt / EBITDA 0.4×
FY 2016 5y median 0.4× FY 2025
Interest Coverage 0.0×
FY 2016 5y median 0.0× FY 2025
Dividends
Dividend Yield 0.0%
FY 2016 5y median 0.0% FY 2025
Payout Ratio 0.0%
FY 2016 5y median 0.0% FY 2025
Annual · latest fiscal year ends 2025-12-31